Traffic Roots Pixel
 

Canada's Le Dain Commission: Vindicated at Last

Posted on October 19th, 2018 by Bill Weinberg and tagged , , , , , , .

Canada legalizationCanada's course to cannabis prohibition closely followed that in its southern neighbor. As in the United States, cannabis a century ago was widely available in tincture form as a medication before being banned in a campaign that blatantly harnessed racism and xenophobia. Yet now Canada is legalizing coast to coast, while the US federal government remains intransigent.

An early harbinger of Canada's enlightenment was the 1969 Le Dain Commission, which studied illegal drugs at the order of Ottawa, in response to then exploding use—especially of cannabis. The Le Dain Commission cut through the propaganda to recommend a common-sense policy—which Canada's government is actually now going beyond.

Canada's First Nations look to legal cannabis economy

Posted on October 9th, 2018 by Global Ganja Report and tagged , , , , , , , , .

CanadaA growing number among Canada's First Nations are looking to legal cannabis as a path to economic empowerment. Others are deeply skeptical, recalling the bitter history of substance abuse among Canada's indigenous communities. Yet all seem united in demanding sovereign control on the cannabis question within their own reserves.

Jamaica begins export of medical marijuana products

Posted on October 5th, 2018 by Global Ganja Report and tagged , , , , , , .

Caribbean A legal medical marijuana export industry is coming to Jamaica, which has just dispatched its first shipment of cannabis oil to Canada. Long famous for its contraband product, the island nation now has a Cannabis Licensing Authority to oversee legal cultivation.

Courts rule for workers denied employment for medical marijuana use

medical marijuanaAfter years of upholding employee firings for use of cannabis even under state medical marijuana programs, the courts are finally starting to turn around on the question.

One of the ways state medical marijuana programs have failed to fully extend protection to medicinal users is in failure to defend against employment discrimination. This is now beginning to change, thanks to a few recent court decisions in favor of patients and employees.

Mother Courage in Peru

Posted on October 3rd, 2018 by Bill Weinberg and tagged , , , , , , , .


The woman behind the South American nation's new medical marijuana law may yet face prison time. Her crime? Providing the only medicine that worked for her ailing son.

In the working-class Lima district of Pueblo Libre, I make my way to an apartment complex and up to the flat of Ana Álvarez—the unlikely woman almost singly responsible for Peru’s groundbreaking new medical marijuana law.

In a bedroom, 18-year-old Anthony watches a noisy Spiderman movie, occasionally interrupting through the open door as I chat with his mom in the living room. Anthony suffers from tuberous sclerosis, a severe form of epilepsy, and was the voiceless central figure behind the events that led to a major reform of Peru’s drug laws in 2017.

FDA called for de-scheduling of CBD: report

Posted on October 3rd, 2018 by Global Ganja Report and tagged , , , , , , , .

cannabisLast month, the DEA enthused the pharmaceutical industry but disappointed cannabis advocates by re-scheduling the drug Epidiolex—but not CBD, the cannabinoid that makes it work. Now word emerges of a letter to the DEA by the Food & Drug Administration essentially calling for the descheduling of CBD altogether.

California passes cannabis equity law

Posted on October 2nd, 2018 by Global Ganja Report and tagged , , , , , , , , , , , , .

CaliforniaAmong several cannabis-related bills signed into law by California's Gov. Jerry Brown was one creating an "equity" program for the state's legalized industry. aimed at justice and inclusion for those communities hardest hit by marijuana prohibition. Another measure will erase past convictions for possession of cannabis in quantities that are now legal.

DEA reschedules Epidiolex —but not CBD

Posted on September 27th, 2018 by Global Ganja Report and tagged , , , , , , , , .

EpidiolexWith the DEA's rescheduling of Epidiolex, shares in the British manufacturer of the drug are soaring. But CBD—the actual cannabinoid that the product is based on—is to remain in the restrictive Scheudle 1.

Who's new

  • Baba Israel
  • Karr Young
  • John Veit
  • YosephLeib
  • Peter Gorman